• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Desipramine plasma concentration and antidepressant response.

作者信息

Nelson J C, Jatlow P, Quinlan D M, Bowers M B

出版信息

Arch Gen Psychiatry. 1982 Dec;39(12):1419-22. doi: 10.1001/archpsyc.1982.04290120049010.

DOI:10.1001/archpsyc.1982.04290120049010
PMID:7149903
Abstract

The relationship of desipramine hydrochloride plasma concentration and antidepressant response was determined in 30 depressed inpatients treated for three weeks with desipramine. All patients had a nondelusional unipolar depression, met DSM-III criteria for major depressive episode with melancholia, and had a Hamilton score of 18 or greater after one week of hospitalization without medication. Eighty-nine percent of the patients with plasma concentrations above 115 ng/mL responded, in contrast to 14% of those with concentrations below this level, a significant difference (Fisher's exact test, P less than .001). Ten initial nonresponders were converted to responders when dosage increase raised desipramine plasma concentration to 125 ng/mL or above. In clinical practice a plasma concentration of 125 ng/mL would be a useful guideline as a threshold above which desipramine is likely to be effective.

摘要

相似文献

1
Desipramine plasma concentration and antidepressant response.
Arch Gen Psychiatry. 1982 Dec;39(12):1419-22. doi: 10.1001/archpsyc.1982.04290120049010.
2
Desipramine plasma levels and response in elderly melancholic patients.
J Clin Psychopharmacol. 1985 Aug;5(4):217-20.
3
Drug-responsive symptoms in melancholia.
Arch Gen Psychiatry. 1984 Jul;41(7):663-8. doi: 10.1001/archpsyc.1984.01790180033004.
4
2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
Int Clin Psychopharmacol. 1996 Dec;11(4):219-27. doi: 10.1097/00004850-199612000-00002.
5
Characteristics of desipramine-refractory depression.
J Clin Psychiatry. 1994 Jan;55(1):12-9.
6
Relationship of desipramine plasma levels to therapeutic response: a critical reappraisal of the data.
J Clin Psychiatry. 1984 Oct;45(10 Pt 2):46-9.
7
Subjective complaints during desipramine treatment. Relative importance of plasma drug concentrations and the severity of depression.
Arch Gen Psychiatry. 1984 Jan;41(1):55-9. doi: 10.1001/archpsyc.1984.01790120059008.
8
Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression.
Am J Psychiatry. 1986 Sep;143(9):1151-4. doi: 10.1176/ajp.143.9.1151.
9
A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression.
Arch Gen Psychiatry. 1991 Apr;48(4):303-7. doi: 10.1001/archpsyc.1991.01810280019002.
10
Depression in children: relationship between plasma imipramine levels and response.
J Clin Psychiatry. 1982 Nov;43(11):450-3.

引用本文的文献

1
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
2
Automated Interlaboratory Comparison of Therapeutic Drug Monitoring Data and Its Use for Evaluation of Published Therapeutic Reference Ranges.治疗药物监测数据的实验室间自动比对及其在已发表治疗参考范围评估中的应用
Pharmaceutics. 2023 Feb 16;15(2):673. doi: 10.3390/pharmaceutics15020673.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2021 Jan 12;51(1):8-58.
4
Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABA receptors.在缺乏含α2的γ-氨基丁酸受体的小鼠中,血清素选择性而非去甲肾上腺素选择性抗抑郁药的促抑郁和类焦虑作用。
Behav Brain Res. 2017 Aug 14;332:172-179. doi: 10.1016/j.bbr.2017.05.063. Epub 2017 Jun 3.
5
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.中等剂量治疗失败后增加抗抑郁药剂量是否为合理策略?一项系统评价。
Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):387-400. doi: 10.1007/s00406-005-0579-5. Epub 2005 Apr 29.
6
Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.氟伏沙明对日本抑郁症患者的临床疗效与氟伏沙明及其主要代谢物氟伏沙明酸稳态血药浓度之间的关系。
Psychopharmacology (Berl). 2003 Jun;167(4):443-8. doi: 10.1007/s00213-003-1430-1. Epub 2003 Apr 8.
7
Therapeutic drug monitoring of psychotropic medications.精神药物的治疗药物监测
Br J Clin Pharmacol. 2000 Apr;49(4):303-12. doi: 10.1046/j.1365-2125.2000.00174.x.
8
Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.电休克疗法和地昔帕明对可乐定激发试验神经内分泌反应的影响。
J Psychiatry Neurosci. 1998 May;23(3):172-8.
9
Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.
Eur J Clin Pharmacol. 1997;51(5):395-8. doi: 10.1007/s002280050220.
10
Pharmacokinetic optimisation of tricyclic antidepressant therapy.三环类抗抑郁药治疗的药代动力学优化
Clin Pharmacokinet. 1993 Apr;24(4):301-18. doi: 10.2165/00003088-199324040-00004.